The Greater Pittsburgh Diabetes Club is a group of multidisciplinary clinicians who have a special interest in diabetes. We provide a venue for non-biased specialty level educational programs, networking, and social interaction.
GPDC provides speakers, continuing education credits, and networking with local friends and colleagues. Please join us for these educational forums and social networking. Your input and participation are encouraged.
Dues are $25/year. Anyone interested in joining the Greater Pittsburgh Diabetes Club or attending a program should contact Michelle Besanceney at 412-321-5030 or email email@example.com .
Dinner and Presentation
“Beta Cell Regeneration for Diabetes: Moving from Impossible to Possible”
Andrew F. Stewart, MD
Director, Diabetes Obesity and Metabolism Institute
Irene and Dr. Arthur M. Fishberg Professor of Medicine
Icahn School of Medicine at Mount Sinai, NY.
Thu, April 30, 2020
6:00 PM – 9:00 PM
Allegheny County Medical Society
713 Ridge Avenue, Pittsburgh, PA 15212
Dr. Stewart is a graduate of Trinity College (BS) and Columbia University, College of Physicians and Surgeons (MD) and did post-doctoral work in Endocrinology at Yale University. He completed his internship and residency at Roosevelt Hospital in New York. Subsequently, he joined the faculty of Yale University School of Medicine. From 1984 until 1997, he served as Chief of Endocrinology at the West Haven VA Medical Center while working as a tenured Professor of Medicine at Yale University School of Medicine. He became Chief, Division of Endocrinology and Professor of Medicine at the University of Pittsburgh in 1997 where he worked until 2012.
For the last 20 years, he has focused on defining human beta cell cycle control, with the goal of developing therapeutic approaches to regenerating the beta cells lost in Type 1 and Type 2 diabetes. In 2015, his research identified the first small molecule agonist of human beta cell proliferation – harmine – using high throughput screening approaches. He then reported the first comprehensive effort to decipher the molecular control mechanisms of human insulinoma to identify key control points for beta cell replication that would serve as drug targets for human beta cell expansion. Finally, in 2019, a number of novel drug combinations were found to induce human beta cell regeneration. He is currently focusing on approaches to target those regenerative drugs to the human beta cell. Among his many distinctions and honors, Dr. Stewart received the Columbia University Alumni Recognition Award for Excellence in Clinical Investigation, The Endocrine Society Gerald D. Aurbach Award for Outstanding Scientific Achievement, and the University of Uppsala Diabetes Center Ray Kroc Scientific Award.
At completion of this seminar:
To better understand the underlying pathophysiology of Type 1 and Type 2 diabetes.
To learn about the difficulties in human beta cell regeneration.
To appreciate the advances made in therapeutic regeneration of endogenous human beta cells in people with diabetes.
CONTINUING EDUCATION INFORMATION
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates this live activity for a maximum of XX AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals: Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
RN, BSN, CDE, CCRC
PharmD, BCPS, BCACP
RN, MSN, CDE, CPT
MD, MS, FACE, FACP CCD, ECNU
RN, MSN, CDE
Greater Pittsburgh Diabetes Club
713 Ridge Avenue
Pittsburgh, PA 15212
412-321-5030 FAX 412-321-5323